Steris (STE) Net Income towards Common Stockholders (2018 - 2026)
Steris (STE) posted quarterly Net Income towards Common Stockholders of -$800000.0 for Q1 2025, up 99.48% year-over-year from -$401039.6 in Q1 2024, and down 700.0% quarter-over-quarter from -$100000.0 in Q4 2024.
Steris (STE) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Steris' Net Income towards Common Stockholders history runs 8 years deep, the most recent figure standing at -$800000.0 for Q1 2025.
- In Q1 2025, Net Income towards Common Stockholders rose 99.48% year-over-year to -$800000.0; the TTM figure through Dec 2025 stood at -$800000.0 (up 99.46% YoY), while the FY2025 annual figure was $4.5 million, up 102.6% from the prior year.
- Net Income towards Common Stockholders for Q1 2025 stood at -$800000.0, down from -$100000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $143.1 million in Q4 2021, with the low at -$439.1 million in Q3 2022.
- The 5-year median for Net Income towards Common Stockholders is -$800000.0 (2025), against an average of -$14.6 million.
- Peak annual rise in Net Income towards Common Stockholders reached 182.46% in 2024, while the deepest fall reached 3338.22% in 2024.
- Steris' Net Income towards Common Stockholders stood at $143.1 million in 2021, then tumbled by 105.37% to -$7.7 million in 2022, then grew by 0.29% to -$7.7 million in 2023, then surged by 98.69% to -$100000.0 in 2024, then tumbled by 700.0% to -$800000.0 in 2025.
- Business Quant data shows STE's Net Income towards Common Stockholders at -$800000.0 in Q1 2025, -$100000.0 in Q4 2024, and -$200000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 201.00 Mn |
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | -154.30 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | -7.68 Mn |
| Sep 30, 2022 | -439.14 Mn |
| Jun 30, 2022 | -8.33 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |
| Jun 30, 2021 | -21.90 Mn |
| Mar 31, 2021 | 86.74 Mn |
| Dec 31, 2020 | 114.59 Mn |
| Sep 30, 2020 | 106.01 Mn |